• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与含依托孕烯避孕植入剂(依伴依)取出困难相关的因素。

Factors associated with removal difficulties of etonogestrel-containing contraceptive implants (Nexplanon).

作者信息

Chevreau Julien, Krief David, Abou Arab Osama, Zitoun Mickaël, Foulon Arthur, Sergent Fabrice, Gondry Jean

机构信息

Amiens-Picardie University Hospital, France.

Amiens-Picardie University Hospital, France.

出版信息

Eur J Obstet Gynecol Reprod Biol. 2018 May;224:81-84. doi: 10.1016/j.ejogrb.2018.03.019. Epub 2018 Mar 13.

DOI:10.1016/j.ejogrb.2018.03.019
PMID:29554605
Abstract

OBJECTIVES

Nexplanon's new applicator system was designed to limit deep implant placements, known to lead to difficult removals. However, removal difficulties still exist and induce specific and potentially severe complications. Our objective was to identify risk factors associated with difficult removals.

STUDY DESIGN

A retrospective single-center study was performed from January 2015 to December 2016. Participants were divided into two groups depending on whether implant was removed during a standard ("standard removal" group) or difficult consultation ("difficult removal" group) after an initial failed removal attempt.

RESULTS

The difficult and standard removal groups comprised 63 and 660 women, respectively. In a univariate analysis, significant intergroup differences were found for weight gain (3.7 ± 7.3 kg in the difficult removal group vs. 1.3 ± 5.1 in the standard removal group), proportion of placements performed in private practice (66.7% vs. 19.8%, respectively), and duration of Nexplanon placement (29.4 ± 11.3 months versus 26 ± 13.6, respectively). We also reported more frequent sub-brachial fascia placements when Nexplanon was implanted by a private practitioner (7.5% cases versus 0.4% in hospital implantations, p < 0.001). In a stepwise binary logistic regression analysis, placement by a private practitioner, weight gain >1 kg since placement, and duration of implant placement >25 months were confirmed as independent risk factors for removal difficulties (respective risk ratios 7.63 [95% IC 4.35-13.33], 2.10 [1.18-3.70], and 1.91 [1.06-3.44], p < 0.05).

CONCLUSIONS

Awareness of these three simple parameters might help physicians to identify "at risk-patients", and suggest a specific consultation before risking a potentially hazardous removal (with its associated, specific morbidity). Our results also emphasize importance of training in implant insertion.

摘要

目的

Nexplanon新型植入器系统旨在减少深部植入,因为深部植入会导致取出困难。然而,取出困难仍然存在,并会引发特定的、可能严重的并发症。我们的目的是确定与取出困难相关的风险因素。

研究设计

2015年1月至2016年12月进行了一项回顾性单中心研究。根据初次取出尝试失败后,植入物是在标准会诊(“标准取出”组)还是困难会诊(“困难取出”组)期间取出,将参与者分为两组。

结果

困难取出组和标准取出组分别包括63名和660名女性。在单因素分析中,发现两组在体重增加方面存在显著差异(困难取出组为3.7±7.3千克,标准取出组为1.3±5.1千克)、私人诊所进行植入的比例(分别为66.7%和19.8%)以及Nexplanon植入持续时间(分别为29.4±11.3个月和26±13.6个月)。我们还报告称,当由私人执业医生植入Nexplanon时,肱下筋膜下植入更为频繁(7.5%的病例,而医院植入为0.4%,p<0.001)。在逐步二元逻辑回归分析中,私人执业医生植入、植入后体重增加>1千克以及植入持续时间>25个月被确认为取出困难的独立风险因素(风险比分别为7.63[95%置信区间4.35 - 13.33]、2.10[1.18 - 3.70]和1.91[1.06 - 3.44],p<0.05)。

结论

了解这三个简单参数可能有助于医生识别“高危患者”,并在进行可能有风险的取出操作(及其相关的特定发病率)之前建议进行特定会诊。我们的结果还强调了植入培训的重要性。

相似文献

1
Factors associated with removal difficulties of etonogestrel-containing contraceptive implants (Nexplanon).与含依托孕烯避孕植入剂(依伴依)取出困难相关的因素。
Eur J Obstet Gynecol Reprod Biol. 2018 May;224:81-84. doi: 10.1016/j.ejogrb.2018.03.019. Epub 2018 Mar 13.
2
A retrospective analysis of factors associated with deep contraceptive implant removals compared to superficial removals.回顾性分析与浅表取出相比,与深部避孕植入物取出相关的因素。
Contraception. 2024 Sep;137:110486. doi: 10.1016/j.contraception.2024.110486. Epub 2024 May 14.
3
Real world data on Nexplanon® procedure-related events: final results from the Nexplanon Observational Risk Assessment study (NORA).关于依伴侬®(Nexplanon®)手术相关事件的真实世界数据:依伴侬观察性风险评估研究(NORA)的最终结果。
Contraception. 2019 Jul;100(1):31-36. doi: 10.1016/j.contraception.2019.03.052. Epub 2019 Apr 10.
4
The effect of immediate postpartum compared to delayed postpartum and interval etonogestrel contraceptive implant insertion on removal rates for bleeding.产后即刻与产后延迟及间隔放置依托孕烯避孕植入剂对因出血导致的取出率的影响。
Contraception. 2014 Sep;90(3):253-8. doi: 10.1016/j.contraception.2014.05.010. Epub 2014 May 24.
5
[Safety profile of etonogestrel contraceptive implant (Nexplanon and Implanon) reported in France].[法国报告的依托孕烯避孕植入剂(依伴依和Implanon)的安全性概况]
J Gynecol Obstet Biol Reprod (Paris). 2016 Nov;45(9):1074-1082. doi: 10.1016/j.jgyn.2016.03.013. Epub 2016 Apr 25.
6
The association between BMI and continuity of etonogestrel (ENG)-releasing implant.体质指数(BMI)与依托孕烯(ENG)释放埋植剂续用的关系。
Int J Gynaecol Obstet. 2024 Oct;167(1):254-258. doi: 10.1002/ijgo.15590. Epub 2024 May 7.
7
Nexplanon, a radiopaque etonogestrel implant in combination with a next-generation applicator: 3-year results of a noncomparative multicenter trial.依托孕诺,一种含新一代给药器的可显影依托孕烯植入剂:一项非对照多中心试验的 3 年结果。
Am J Obstet Gynecol. 2012 Nov;207(5):388.e1-6. doi: 10.1016/j.ajog.2012.08.002. Epub 2012 Aug 10.
8
Six- and twelve-month documented removal rates among women electing postpartum inpatient compared to delayed or interval contraceptive implant insertions after Medicaid payment reform.与医疗补助支付改革后延迟或间隔植入避孕植入物相比,选择产后住院的女性在6个月和12个月时有记录的取出率。
Contraception. 2017 Jan;95(1):71-76. doi: 10.1016/j.contraception.2016.07.004. Epub 2016 Jul 8.
9
Delayed-type hypersensitivity reaction against Nexplanon®.对依伴侬(Nexplanon®)的迟发型超敏反应。
Contraception. 2015 Jan;91(1):91-2. doi: 10.1016/j.contraception.2014.08.014. Epub 2014 Sep 17.
10
Neuropathy associated with etonogestrel implant insertion.与依托孕烯植入剂插入相关的神经病变。
Contraception. 2012 Nov;86(5):591-3. doi: 10.1016/j.contraception.2012.05.014. Epub 2012 Jul 6.

引用本文的文献

1
Reversible median nerve neuropathy and local muscle irritation resulting from blind removal attempts of etonogestrel contraceptive implant: a case report.依托孕烯避孕植入剂盲目取出尝试导致的可逆性正中神经病变和局部肌肉刺激:一例报告
Contracept Reprod Med. 2023 Dec 1;8(1):57. doi: 10.1186/s40834-023-00257-5.
2
Infective Endocarditis in Hypertrophic Obstructive Cardiomyopathy After Etonogestrel Implant Removal.依托孕烯植入剂取出术后肥厚型梗阻性心肌病并发感染性心内膜炎
Cureus. 2022 Oct 1;14(10):e29810. doi: 10.7759/cureus.29810. eCollection 2022 Oct.
3
Making Removals Part of Informed Choice: A Mixed-Method Study of Client Experiences With Removal of Long-Acting Reversible Contraceptives in Senegal.
将移除作为知情选择的一部分:塞内加尔关于移除长效可逆避孕措施的客户体验的混合方法研究。
Glob Health Sci Pract. 2022 Oct 31;10(5). doi: 10.9745/GHSP-D-22-00123.
4
Characteristics of Patients Requiring Surgical Removal of Subdermal Contraceptive Implants: A Case-Control Study.需要手术取出皮下避孕植入物的患者特征:一项病例对照研究。
Open Access J Contracept. 2022 Aug 8;13:111-119. doi: 10.2147/OAJC.S368250. eCollection 2022.
5
Nexplanon removal from intramuscular implantation in biceps: case report.从肱二头肌肌内植入部位取出皮下埋植剂:病例报告。
Radiol Case Rep. 2021 Oct 22;16(12):3973-3976. doi: 10.1016/j.radcr.2021.09.051. eCollection 2021 Dec.
6
Contraceptive subcutaneous device migration: what does an orthopaedic surgeon need to know? A case report and literature review.避孕皮下装置迁移:骨科医生需要了解什么?病例报告和文献复习。
Acta Biomed. 2020 May 30;91(4-S):232-237. doi: 10.23750/abm.v91i4-S.9498.
7
Difficult etonogestrel implant removals in South Africa: A review of 74 referred cases.南非困难去氧孕烯皮下埋植取出术:74 例转诊病例回顾。
Contraception. 2020 Aug;102(2):129-132. doi: 10.1016/j.contraception.2020.04.013. Epub 2020 Apr 24.
8
Migration of etonogestrel contraceptive implants: Implications for difficult removals services need in southern Africa.依托孕诺酮避孕植入剂的迁移:对南部非洲困难移除服务的影响。
S Afr Med J. 2019 Jul 26;109(8):559-561. doi: 10.7196/SAMJ.2019.v109i8.14061.
9
Advanced implantable drug delivery technologies: transforming the clinical landscape of therapeutics for chronic diseases.先进的植入式药物输送技术:改变慢性疾病治疗的临床格局。
Biomed Microdevices. 2019 May 18;21(2):47. doi: 10.1007/s10544-019-0389-6.
10
Indicator Layers Based on Ethylene-Vinyl Acetate Copolymer (EVA) and Dicyanovinyl Azobenzene Dyes for Fast and Selective Evaluation of Vaporous Biogenic Amines.基于乙烯-醋酸乙烯共聚物(EVA)和二氰基乙烯基偶氮苯染料的指示剂层,用于快速和选择性评估蒸气态生物胺。
Sensors (Basel). 2018 Dec 10;18(12):4361. doi: 10.3390/s18124361.